Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Jun 19;15:1355269. doi: 10.3389/fphar.2024.1355269

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2024 Lin, Yang, Wang, Huang, Wang, Chen, Xu, Cai, Khan, Liu and Lin.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Identification and validation of M2 macrophage-related risk genes. (A) Violin plot of abundance of 22 subtypes of immune cells in risk subgroups. (B) Spearman’s correlation between infiltration of 22 subtypes of immune cells and individual TME-Met PI genes (n = 15) in TCGA STAD cohort. p values are shown as: *p < 0.05; **p < 0.01; ***p < 0.001. (C) UMAP plots and (D) Violin plots showing expression patterns of CPVL, KYNU, CD36, and GPX3 in single-cell gastric cancer dataset (GSE112302). (E) UMAP plots showing expression patterns of CPVL, KYNU, CD36, and GPX3 in GSE167297 dataset. (F) Representative images of expression (brown, cell cytoplasmic/nucleus stain) and ( G ) IHC quantification of expression level of CPVL, KYNU, CD36, and GPX3 and marker of M2 macrophage (CD163) in the clinical samples of stomach adenocarcinoma (n = 8). ( H ) Pearson’s correlation of expression level of CPVL, KYNU, CD36, and GPX3 and marker of M2 macrophage (CD163) in the clinical samples of stomach adenocarcinoma.